세계의 효소면역측정법 시장 보고서(2025년)

Enzyme immunoassay is a highly sensitive laboratory technique that utilizes antibodies conjugated with enzymes to specifically identify and quantify target molecules such as proteins, hormones, or infectious agents within a sample. The method is based on an enzymatic reaction that generates a detectable signal-often a color change-which correlates directly with the concentration of the analyte, enabling accurate diagnostic or research analysis.

The primary product types in enzyme immunoassay include reagents and kits, analyzers or instruments, and software and services. Reagents and kits consist of chemical substances or pre-packaged sets of chemicals used in laboratory and clinical testing to detect, measure, or process other substances. These products accommodate various specimen types, such as blood, saliva, urine, and others, and support a wide array of applications, including therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease detection, autoimmune disease testing, and more. They serve a broad range of end users, including hospitals, blood banks, clinical laboratories, pharmaceutical and biotechnology companies, academic research centers, and other institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The enzyme immunoassay market research report is one of a series of new reports from The Business Research Company that provides enzyme immunoassay market statistics, including enzyme immunoassay industry global market size, regional shares, competitors with an enzyme immunoassay market share, detailed enzyme immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme immunoassay industry. This enzyme immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enzyme immunoassay market size has grown strongly in recent years. It will grow from $20.01 billion in 2024 to $21.50 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to the increasing prevalence of infectious diseases, the expansion of blood screening programs, advancements in laboratory infrastructure, the growing application of enzyme immunoassays in food safety testing, and the rising demand for veterinary diagnostics.

The enzyme immunoassay market size is expected to see strong growth in the next few years. It will grow to $28.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to government and NGO-driven disease control initiatives, the emergence of autoimmune disease detection, increased adoption of point-of-care testing, rising demand for companion diagnostics in oncology, and a growing geriatric population. Key trends anticipated during this period include technological advancements in microplate readers and reagents, the introduction of innovative diagnostic technologies, development of environmentally friendly reagents, integration of AI and automation into immunoassay processes, and an increase in strategic collaborations and partnerships.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the enzyme immunoassay market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted between individuals. The burden of these diseases is growing due to rising antimicrobial resistance, which complicates treatment, extends recovery times, raises healthcare costs, and leads to increased mortality. Enzyme immunoassays are essential tools for diagnosing infectious diseases, offering sensitive and specific detection of antigens or antibodies in patient samples. This facilitates early diagnosis, effective monitoring, and timely treatment for conditions such as HIV, hepatitis, and influenza. For example, in April 2025, the Minnesota Department of Health, a US-based government agency, reported that the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, reflecting a significant rise in this demographic. As a result, the increasing burden of infectious diseases is contributing to the expansion of the enzyme immunoassay market.

Leading companies in the enzyme immunoassay market are prioritizing the development of advanced solutions, such as fully automated enzyme immunoassays, to boost diagnostic accuracy, reduce human error, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays streamline the entire testing process, enhancing the speed, precision, and reliability of laboratory diagnostics. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics company, introduced the fully automated Lumipulse G GFAP assay for research use only (RUO), expanding its neuro-biomarker product line. This chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) levels in human plasma and serum using the LUMIPULSE G platform, delivering results within 35 minutes. GFAP is an astrocytic biomarker associated with neurological conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, stroke, and traumatic brain injury. This new assay complements Fujirebio's neurodegenerative disease portfolio, which already includes markers like NfL, pTau217, and sTREM2, supporting comprehensive profiling on a single automated platform.

In January 2025, Medix Biochemica, a Finland-based supplier of raw materials for in vitro diagnostics, acquired CANDOR Bioscience GmbH for an undisclosed sum. This acquisition is aimed at strengthening Medix Biochemica's position as a leading global provider in the IVD industry by expanding its portfolio with CANDOR's specialized expertise in high-performance blockers and assay optimization reagents. These technologies support improved performance in enzyme immunoassays and enable more robust diagnostic test development. CANDOR Bioscience GmbH is a Germany-based biotechnology company that focuses on optimizing immunoassay systems, including enzyme immunoassays and ELISA development.

Major players in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, and Calbiotech Inc.

North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enzyme immunoassay report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the enzyme immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme immunoassay market consists of sales of enzyme-labeled antibodies, sample diluents, blocking reagents, microplate readers, ELISA test kits, robotic liquid handling systems, and plate washers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzyme immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
• 2) By Specimen: Blood; Saliva; Urine; Other Specimens
• 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
• 4) By End-Use: Hospitals; Blood Banks; Clinical Laboratories; Pharmaceutical And Biotech Companies; Academic Research Centers; Other End-Uses
• Subsegments:
• 1) By Reagents And Kits: Antibodies; Antigens; Substrates; Buffers And Stabilizers
• 2) By Analyzers Or Instruments: Fully Automated EIA Analyzers; Semi-Automated EIA Systems; Microplate Readers; Washers And Incubators
• 3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information System Integration Tools; Instrument Calibration And Validation Services; Technical Support And User Training
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG; Becton Dickinson and Company (BD); PerkinElmer Inc.; BioMerieux SA; Bio-Rad Laboratories Inc.; Diasorin S.p.A.; Bio-Techne Corporation; Quidel Corporation; Promega Corporation; Abcam plc; BioLegend Inc.; Helena Laboratories Corporation; Cayman Chemical Company; Enzo Life Sciences Inc.; RayBiotech Inc.; MyBioSource Inc.; Boster Biological Technology; Hycult Biotech; Calbiotech Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzyme Immunoassay Market Characteristics

3. Enzyme Immunoassay Market Trends And Strategies

4. Enzyme Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Enzyme Immunoassay Growth Analysis And Strategic Analysis Framework

• 5.1. Global Enzyme Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Enzyme Immunoassay Market Growth Rate Analysis
• 5.4. Global Enzyme Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Enzyme Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Enzyme Immunoassay Total Addressable Market (TAM)

6. Enzyme Immunoassay Market Segmentation

• 6.1. Global Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Analyzers Or Instruments
• Software And Services
• 6.2. Global Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Saliva
• Urine
• Other Specimens
• 6.3. Global Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Other Applications
• 6.4. Global Enzyme Immunoassay Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Blood Banks
• Clinical Laboratories
• Pharmaceutical And Biotech Companies
• Academic Research Centers
• Other End-Uses
• 6.5. Global Enzyme Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies
• Antigens
• Substrates
• Buffers And Stabilizers
• 6.6. Global Enzyme Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fully Automated EIA Analyzers
• Semi-Automated EIA Systems
• Microplate Readers
• Washers And Incubators
• 6.7. Global Enzyme Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis And Interpretation Software
• Laboratory Information System Integration Tools
• Instrument Calibration And Validation Services
• Technical Support And User Training

7. Enzyme Immunoassay Market Regional And Country Analysis

• 7.1. Global Enzyme Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Enzyme Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzyme Immunoassay Market

• 8.1. Asia-Pacific Enzyme Immunoassay Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzyme Immunoassay Market

• 9.1. China Enzyme Immunoassay Market Overview
• 9.2. China Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzyme Immunoassay Market

• 10.1. India Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzyme Immunoassay Market

• 11.1. Japan Enzyme Immunoassay Market Overview
• 11.2. Japan Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzyme Immunoassay Market

• 12.1. Australia Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzyme Immunoassay Market

• 13.1. Indonesia Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzyme Immunoassay Market

• 14.1. South Korea Enzyme Immunoassay Market Overview
• 14.2. South Korea Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzyme Immunoassay Market

• 15.1. Western Europe Enzyme Immunoassay Market Overview
• 15.2. Western Europe Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzyme Immunoassay Market

• 16.1. UK Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzyme Immunoassay Market

• 17.1. Germany Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzyme Immunoassay Market

• 18.1. France Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzyme Immunoassay Market

• 19.1. Italy Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzyme Immunoassay Market

• 20.1. Spain Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzyme Immunoassay Market

• 21.1. Eastern Europe Enzyme Immunoassay Market Overview
• 21.2. Eastern Europe Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzyme Immunoassay Market

• 22.1. Russia Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzyme Immunoassay Market

• 23.1. North America Enzyme Immunoassay Market Overview
• 23.2. North America Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzyme Immunoassay Market

• 24.1. USA Enzyme Immunoassay Market Overview
• 24.2. USA Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzyme Immunoassay Market

• 25.1. Canada Enzyme Immunoassay Market Overview
• 25.2. Canada Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzyme Immunoassay Market

• 26.1. South America Enzyme Immunoassay Market Overview
• 26.2. South America Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzyme Immunoassay Market

• 27.1. Brazil Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzyme Immunoassay Market

• 28.1. Middle East Enzyme Immunoassay Market Overview
• 28.2. Middle East Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzyme Immunoassay Market

• 29.1. Africa Enzyme Immunoassay Market Overview
• 29.2. Africa Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzyme Immunoassay Market Competitive Landscape And Company Profiles

• 30.1. Enzyme Immunoassay Market Competitive Landscape
• 30.2. Enzyme Immunoassay Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Enzyme Immunoassay Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers AG
• 31.2. Becton Dickinson and Company (BD)
• 31.3. PerkinElmer Inc.
• 31.4. BioMerieux SA
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Diasorin S.p.A.
• 31.7. Bio-Techne Corporation
• 31.8. Quidel Corporation
• 31.9. Promega Corporation
• 31.10. Abcam plc
• 31.11. BioLegend Inc.
• 31.12. Helena Laboratories Corporation
• 31.13. Cayman Chemical Company
• 31.14. Enzo Life Sciences Inc.
• 31.15. RayBiotech Inc.

32. Global Enzyme Immunoassay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzyme Immunoassay Market

34. Recent Developments In The Enzyme Immunoassay Market

35. Enzyme Immunoassay Market High Potential Countries, Segments and Strategies

• 35.1 Enzyme Immunoassay Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Enzyme Immunoassay Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Enzyme Immunoassay Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer